Nordea Investment Management Ab Dynavax Technologies Corp Transaction History

Nordea Investment Management Ab

$103 Billion
Q2 2025

A detailed history of Nordea Investment Management Ab transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Nordea Investment Management Ab holds 782,248 shares of DVAX stock, worth $8.83 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

782,248

Previous 779,077 0.41%

Holding current value

$8.83 Million

Previous $10.1 Million 23.21%

% of portfolio

0.01%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 29, 2025	BUY	$9.4 - $12.87 $29,807 - $40,810	3,171 Added 0.41%	782,248 $7.76 Million
Q1 2025 May 14, 2025	BUY	$12.39 - $14.4 $15,623 - $18,158	1,261 Added 0.16%	779,077 $10.1 Million
Q4 2024 Jan 06, 2025	BUY	$10.28 - $13.66 $2.39 Million - $3.18 Million	232,690 Added 42.69%	777,816 $9.93 Million
Q3 2024 Nov 05, 2024	BUY	$10.05 - $11.61 $2.21 Million - $2.56 Million	220,298 Added 67.82%	545,126 $6.07 Million
Q2 2024 Aug 08, 2024	SELL	$10.73 - $12.58 $739,865 - $867,428	-68,953 Reduced 17.51%	324,828 $3.65 Million
Q1 2024 May 02, 2024	BUY	$11.7 - $14.98 $862,067 - $1.1 Million	73,681 Added 23.02%	393,781 $4.89 Million
Q4 2023 Jan 10, 2024	SELL	$13.09 - $14.98 $94,967 - $108,679	-7,255 Reduced 2.22%	320,100 $4.47 Million
Q3 2023 Nov 13, 2023	BUY	$12.64 - $14.99 $26,329 - $31,224	2,083 Added 0.64%	327,355 $4.84 Million
Q2 2023 Jul 07, 2023	BUY	$9.85 - $13.17 $590,182 - $789,106	59,917 Added 22.58%	325,272 $4.2 Million
Q1 2023 Apr 19, 2023	SELL	$9.44 - $11.88 $36,646 - $46,118	-3,882 Reduced 1.44%	265,355 $2.6 Million
Q4 2022 Feb 08, 2023	BUY	$10.27 - $13.29 $1.11 Million - $1.43 Million	107,846 Added 66.82%	269,237 $2.86 Million
Q3 2022 Oct 19, 2022	BUY	$9.93 - $17.44 $19,343 - $33,973	1,948 Added 1.22%	161,391 $1.7 Million
Q2 2022 Aug 09, 2022	BUY	$7.45 - $12.83 $90,957 - $156,641	12,209 Added 8.29%	159,443 $1.96 Million
Q1 2022 Apr 11, 2022	BUY	$9.75 - $14.44 $1.25 Million - $1.85 Million	128,230 Added 674.75%	147,234 $1.7 Million
Q4 2021 Jan 20, 2022	BUY	$13.17 - $20.94 $250,282 - $397,943	19,004 New	19,004 $270,000

Others Institutions Holding DVAX

# of Institutions

304

Shares Held

129M

Call Options Held

493K

Put Options Held

269K

View Full List

About DYNAVAX TECHNOLOGIES CORP

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.43B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

More about DVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nordea Investment Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Nordea Investment Management Ab with notifications on news.

Account

Nordea Investment Management Ab Dynavax Technologies Corp Transaction History